Mode
Text Size
Log in / Sign up

Narrative review of oxidative stress and antioxidant defense in periodontitis and peri-implantitisOxidative stress may drive gum disease and bone loss

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that antioxidant interventions show promise as adjunctive therapies, but clinical outcomes remain variable.

This narrative review explores the mechanisms of oxidative stress and the role of antioxidant defense systems in the context of periodontitis and peri-implantitis. The authors focus on how excessive reactive oxygen species (ROS) generation activates redox-sensitive signaling pathways, including NF-κB, MAPKs, and AP-1. This activation is associated with sustained cytokine production, mitochondrial dysfunction, matrix metalloproteinase activation, and enhanced osteoclastogenesis.

The review also discusses the association of oxidative stress biomarkers, such as malondialdehyde, 8-hydroxy-2' deoxyguanosine, and protein carbonyls, with disease severity and treatment response. Regarding therapeutic approaches, the authors evaluate antioxidant-based interventions, including systemic supplementation, local delivery systems, nano-formulations, and antioxidant-enriched biomaterials. These strategies show promising adjunctive effects, though the authors note that clinical outcomes are currently variable.

Several limitations are identified in the current evidence. The clinical utility of biomarkers is constrained by methodological heterogeneity and a lack of standardization. Furthermore, the effectiveness of antioxidant interventions is impacted by differences in dosage, bioavailability, and patient-specific factors. Targeting redox imbalance may provide a framework for improving diagnostics, risk stratification, and host-modulatory therapy, but further standardized research is required.

Losing the bone that supports your teeth is a scary prospect. When you deal with periodontitis or peri-implantitis (inflammation around dental implants), it is not just about bacteria. A growing body of evidence shows that oxidative stress, which is an imbalance between harmful molecules and your body's natural defenses, helps drive the damage.

Researchers found that when your body produces too many reactive oxygen species (harmful molecules), it triggers specific biological pathways. These pathways lead to sustained inflammation, cell dysfunction, and the activation of cells that actually break down bone. This process makes the disease much harder for your body to fight on its own.

There is some good news on the horizon. Using antioxidants through supplements or specialized dental materials shows promise as an extra way to help treat these conditions. However, we are still in the early stages. Because every patient reacts differently to doses and delivery methods, the clinical results remain variable.

We also cannot rely on biomarkers (signals in the body) just yet. Right now, the lack of standardized testing makes it difficult to use these markers for clear diagnoses. While the potential to improve how we detect and treat gum disease is huge, more consistent research is needed to make these tools a reality in your dentist's office.

What this means for you:
Oxidative stress helps drive bone loss in gum disease, offering a new target for future dental treatments.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Periodontitis and peri-implantitis are chronic, immune-mediated inflammatory diseases characterized by progressive destruction of tooth- and implant-supporting tissues. Although microbial dysbiosis initiates these conditions, accumulating evidence indicates that host-derived oxidative stress plays a central role in amplifying inflammation, impairing tissue repair, and driving irreversible bone loss. Excessive production of reactive oxygen species (ROS) disrupts redox homeostasis, induces molecular damage, and activates redox-sensitive signaling pathways that perpetuate tissue destruction. This narrative review synthesizes current mechanistic, clinical, and translational evidence on the role of oxidative stress and antioxidant defense systems in the pathogenesis of periodontitis and peri-implantitis. It further aims to critically evaluate redox-regulated molecular pathways, emerging diagnostic biomarkers, and antioxidant-based therapeutic strategies. A structured literature search was conducted using PubMed, Scopus, and Web of Science, focusing on recent experimental, clinical, and translational studies. Articles were selected based on relevance, methodological rigor, and translational applicability, with emphasis on studies addressing oxidative stress mechanisms, biomarker validity, and therapeutic interventions. Evidence indicates that excessive ROS generation activates key redox-sensitive signaling pathways, including NF-κB, MAPKs, and AP-1, leading to sustained cytokine production, matrix metalloproteinase activation, mitochondrial dysfunction, and enhanced osteoclastogenesis. Concurrent impairment of endogenous antioxidant systems further exacerbates tissue vulnerability. Oxidative stress biomarkers—such as malondialdehyde, 8-hydroxy-2′-deoxyguanosine, and protein carbonyls—demonstrate associations with disease severity and treatment response; however, their clinical utility is limited by methodological heterogeneity and lack of standardization. Antioxidant-based interventions, including systemic supplementation, local delivery systems, nano-formulations, and antioxidant-enriched biomaterials, show promising adjunctive effects, although clinical outcomes remain variable due to differences in bioavailability, dosage, and patient-specific factors. Oxidative stress represents a central, disease-modifying axis in periodontitis and peri-implantitis. Targeting redox imbalance offers a biologically grounded framework for improving diagnostics, risk stratification, and host-modulatory therapy. However, translation into clinical practice requires standardized biomarker validation and rigorously designed, biomarker-guided clinical trials. Future strategies integrating redox biology with advanced delivery systems and precision medicine approaches may significantly enhance periodontal and peri-implant care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.